Tuoxin Pharmaceutical announced that its wholly-owned subsidiary Tuoxin Pharmaceutical Co., Ltd. recently obtained a “Pharmaceutical Production License” issued by the Hainan Drug Administration. The scope of production includes tablets and capsules, and the production line covers etoglidine tablets and dotinolide tablets. Obtaining a license this time indicates that the subsidiary's solid preparation workshop has the corresponding production qualification conditions, which is conducive to promoting subsequent registration and declaration of related formulation varieties. Etoglide tablets and dortinolide tablets have yet to obtain drug registration approval numbers, and there is uncertainty about whether they will be approved, when they will be approved, and subsequent commercial production.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.